£520.00

CRC Press Antiangiogenic Cancer Therapy

Name: Antiangiogenic Cancer Therapy
Brand: CRC Press
Price: 520.0 GBP
Availability: InStock

Oncology

This is the most expensive it has ever been. Walk away.

£520 today · previous high £520 · all-time low £262

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 73 days · 73 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 73 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £305 (33 days, 45.2%)

Price range: £262 - £520

Price levels: 3 different prices over 73 days

Description

Top Investigators Explore the Complexities of Angiogenesis Cancer Research The targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies. However, as of yet, no antiangiogenic agent used as a monotherapy has demonstrated a survival benefit in a randomized Phase III trial. The combination of bevacizumab, the first FDA approved angiogenesis inhibitor, with cytotoxic regimens has led to survival benefits in cancer patients. This has raised important questions about the complexities inherent in the clinical application of angiogenesis inhibitors. Compiles the results of four decades of progress Integrating fundamental concepts with therapeutic strategies, Anti-Angiogenic Cancer Therapy promotes the idea that an understanding of the molecular and cellular regulation of angiogenesis leads to optimal therapeutic strategies and positive clinical results. It brings together contributions from leading researchers to provide the most authoritative and encyclopedic volume available on this subject. Examines the role of angiogenesis in cancer, including strategies to prolong the nonangiogenic dormant state of human tumors, molecular mechanisms and cellular regulation of angiogenesis in solid tumors and hematologic malignancies, and the regulation of angiogenesis by the tumor microenvironment. Covers specific molecular targets for inhibiting angiogenesis in cancer therapy. Discusses clinical trial design and translational research approaches essential for identifying and developing effective angiogenesis inhibitors. Outlines current understanding of the molecular biology of each cancer type followed by discussions that examine strategies for targeting angiogenesis in specific cancers. This volume celebrates progress made in four decades, and more importantly, it provi About the Author Darren W. Davis, Roy S. Herbst, James L. Abbruzzese

Key Features

Used Book in Good Condition

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 0849327997
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 25 July 2007
Listed Since: 01 February 2007

Barcode

No barcode data available

CRC Press Antiangiogenic Cancer Therapy

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

The Biology of Tumors: 9 (Pezcoller Foundation Symposia, 9)

Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)

Medicines for Cancer: Mechanism of Action and Clinical Pharmacology of Chemo, Hormonal, Targeted, and Immunotherapies

Animal Models in Cancer Drug Discovery

A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy

The Tumor Microenvironment (Cancer Drug Discovery and Development)

Abeloff's Clinical Oncology

A Beginner's Guide to Targeted Cancer Treatments

Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy

Cancer Chemotherapy: Basic Science to the Clinic

Evolution-adjusted Tumor Pathophysiology:: The Novel Language of Tumor Biology

Springer - Signaling Pathways and Molecular Mediators in Metastasis

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease

Cancer Biology

Onco-Nephrology

The Basic Science of Oncology, Sixth Edition (MEDICAL/DENISTRY)

Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)

Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-oncology: From Basic Research to Advanced Study

Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)

Vascular Surgery in Oncology

Guidance Molecules in Cancer and Tumor Angiogenesis (Advances in Cancer Research): Volume 114

Evidence–Based Oncology (Evidence–Based Medicine)

The Story of Hydra: Portrait of Cancer as a Stem-Cell Disease